Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07787533 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07787533 · ClinicalTrials.gov record · last posted 2026-08-26

Digital Resistance Training for Midlife Women Using GLP-1

Study acronym: PLAN-RT
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-11-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of PLAN-RT 1.0 to learn if a 12-week app-based strength training program can help midlife women build and stick with a regular strength training routine while they are taking GLP-1 medication for weight loss. PLAN-RT 1.0 targets women ages 40 to 59 who were not regularly exercising before starting GLP-1 medication. The main questions this study aims to answer are: (1) Is the PLAN-RT 1.0 program feasible and acceptable to participants (based on how many people join, stay in the study, and use the program)? (2) Does the program lead to early changes in muscle strength, body composition, physical function, and exercise habits?
Trial Details
NCT Number NCT07787533
Lead Sponsor Louisiana State University and A&M College
Collaborators: Louisiana Clinical and Translational Science Center, Pennington Biomedical Research Center
Conditions Women's Health, Obesity & Overweight, Perimenopausal Women, Digital Intervention, Behavior Change, glp1 Agonist, Resistance Exercise
Enrollment 15 participants
Start Date 2026-11-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-26